PHP
CYRX icon

Parkman Healthcare Partners’s CryoPort CYRX Stock Holding History

Parkman Healthcare Partners’s Portfolio CYRX Stock Details CYRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.98M Buy
+508,324
New +$6.52M 0.82% 45

Other funds holding CYRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Parkman Healthcare Partners's CYRX Position: Q2 2026 in Review

Parkman Healthcare Partners opened a new position in CryoPort (CYRX) in Q2 2026: 508,324 shares worth $7.98M. The stake represents 0.82% of the portfolio and ranks #45 among its holdings.

185 funds tracked by Wall St. Rank hold CYRX as of Q2 2026.

  • Parkman Healthcare Partners held 508,324 shares of CryoPort worth $7.98M as of Q2 2026.
  • CryoPort was a new Parkman Healthcare Partners position in Q2 2026.
  • CryoPort made up 0.82% of Parkman Healthcare Partners's portfolio in Q2 2026, its #45 holding.
  • 185 funds tracked by Wall St. Rank held CryoPort as of Q2 2026.

Based on Parkman Healthcare Partners's 13F filing for Q2 2026, filed 14 Aug 2026.